BIOMARIN PHARMACEUTICAL INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Biomarin Pharmaceutical Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q4 2023.
  • Biomarin Pharmaceutical Inc Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $42.7M, a 22.3% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $42.7M +$7.8M +22.3% Dec 31, 2023 10-K 2024-02-26
Q4 2022 $34.9M -$3.26M -8.54% Dec 31, 2022 10-K 2024-02-26
Q4 2021 $38.2M -$7.82M -17% Dec 31, 2021 10-K 2023-02-27
Q4 2020 $46M -$3.03M -6.18% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $45.8M -$5.52M -10.8% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $47.2M -$3.95M -7.72% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $49.1M +$4.89M +11.1% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $49M Dec 31, 2019 10-K 2021-02-26
Q3 2019 $51.3M Sep 30, 2019 10-Q/A 2019-11-04
Q2 2019 $51.2M Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $44.2M Mar 31, 2019 10-Q 2019-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.